Effect of misoprostol on acute cisplatin nephrotoxicity

Kurt E., Manavoglu O., Dilek K., Orhan B., Evrensel T.

2nd Congress of the Balkan-Union-of-Oncology, İzmir, Turkey, 10 - 14 September 1998, pp.401-406 identifier

  • Publication Type: Conference Paper / Full Text
  • Volume:
  • City: İzmir
  • Country: Turkey
  • Page Numbers: pp.401-406


Protective effects of misoprostol on non steroidal antiinflammatory drugs (NSAIDs) and cyclosporine nephrotoxicity is well described in the literature, but the role of misoprostol in cisplatin nephrotoxicity is not fully understood. In our study, we planned to investigate the protective effect of misoprostol in acute cisplatin nephrotoxicity. Our patient group consisted 28 patient with lung cancer. All patients received cisplatin + etoposide chemotherapy regimen. The patients were divided into two groups. Misoprostol Group (14 patients); was given misoprostol 100 mu g qid (po) during chemotherapy. Control Group (14 patients); only received chemotherapy. Glomerular and proximal tubular functions were measured in both groups before the onset of chemotherapy and on the 2(nd) and 6(th) days of chemotherapy. As a result of our study, we have not been able to show the protective effect of misoprostol in tubular and glomerular functional disturbances due to cisplatin administration.